Optive AI
AI-driven image reconstruction software for ultra-low-field portable MRI
Company profile
Company profile
Hyperfine, Inc. (Nasdaq: HYPR) is a groundbreaking health technology company that has redefined brain imaging with the Swoop system—the first FDA-cleared, portable, ultra-low-field magnetic resonance brain imaging system capable of providing imaging at multiple points of care within healthcare facilities. Founded in 2014 by serial entrepreneur Jonathan Rothberg, PhD, Hyperfine's mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. The Swoop system is an AI-powered portable brain MRI that uses a magnet with a fraction of the field strength (0.064T) used in conventional MRI. This breakthrough enables the device to be brought directly to the point of care and used safely in almost any care setting without the need for dedicated staff or infrastructure. The system simply plugs into a standard electrical outlet and is ready to use in minutes, with an intuitive interface that any trained healthcare professional can operate. Powered by Optive AI software, the Swoop system brings advanced, AI-driven image reconstruction to ultra-low-field portable MRI, reducing noise and blur with deep learning to enhance image clarity and consistency. The system provides diagnostic-quality imaging across multiple sequences including T1, T2, FLAIR, and DWI in axial, coronal, and sagittal planes. Its open design and quieter operation enhance patient comfort and reduce anxiety, while eliminating exposure to ionizing radiation. Hyperfine serves diverse healthcare settings including hospital ICUs and emergency departments, neurology clinics, pediatric facilities, and underserved global markets. The company partners with organizations like the Gates Foundation, Raising Malawi, and the Hydrocephalus Association to expand access to neuroimaging in low- and medium-income countries. Hyperfine went public in December 2021, with Class A common stock trading on Nasdaq under the symbol HYPR.
Company description Hyperfine Research, Inc official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Embedded · On Premise deployment with recorded integration context.
Company milestones
IPO in December 2021 on Nasdaq. Deployment of Swoop systems across multiple research and clinical study sites globally. Launch of Optive AI software for enhanced image reconstruction.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI-driven image reconstruction software for ultra-low-field portable MRI
AI-powered portable brain MRI using ultra-low-field (0.064T) technology for point-of-care imaging
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
NCT04629469 · Mentioned · RECRUITING
Point-of-care Low-field MRI in Acute StrokeNCT05816213 · Mentioned · NOT YET RECRUITING
Regulatory
K202414 · 510k · Jan 7, 2021
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Enables timely informed clinical decisions at point of care
More effective, scalable stroke programs
Imaging for patients who cannot undergo traditional MRI
Providing pediatric brain imaging in Malawi's first and only pediatric surgery and intensive care hospital, supporting critical care for infants and children
05 · Leadership
Leadership profiles and professional links from the current Company record.
Maria Sainz
President and CEO
Brett Hale
Chief Administrative Officer and Chief Financial Officer
Tom Teisseyre
Chief Operating Officer
Rob Fasciano
Chief Regulatory and Quality Officer
Edmond Knopp
Chief Medical Officer
Rafael Donnay
Senior Vice President of Hospital Business
Chi Nguyen
Senior Vice President of Office and Community Business
Todd Finch
Vice President of US Sales
06 · Company updates
Recent articles published on Hyperfine Research, Inc's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies that apply AI to analyze medical images for diagnostic purposes, workflow optimization, or clinical decision support. Covers general radiology (X-rays, CT scans, MRIs, ultrasounds) across multiple organ systems, as well as specialized imaging in ophthalmology and dermatology.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.